Summary
Inhibition of angiogenesis offers an alternative approach to cancer chemotherapy, since solid tumor growth has an absolute dependency on angiogenesis. We have previously shown that 8,9-dihydroxy-7-methyl-benzo [b]quinolizinium bromide (GPA1734) is a basement membrane synthesis inhibitor, and that this compound acts as an antiangiogenic agent in the chick chorioallantoic membrane.
When a piece of 10 mg from a Walker 256 carcinoma was implated into the peritoneal cavity of rats, tumor grew to about 15 g within nine days after transplant. Daily treatment of Walker 256 carcinoma bearing animals with GPA1734, at doses 10–100 mg/kg intraperitoneally, restrained tumor growth in a dose dependent manner. Macroscopic examination showed tumor cells growing in spherical masses 5–8 mm in diameter, indicative of absence of neovascularization. GPA1734 at 300 μM had no direct effect on Walker 256 carcinoma cell culture growth. The antitumor effect of this agent on Walker 256 carcinoma may be related to its antiangiogenic properties.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Folkman J, Merler E, Abernathy C, Williams G: Isolation of a tumor factor responsible for angiogenesis. J Exp Med 133:275–288, 1971
Auerbach R, Kubai L, Sidky Y: Angiogenesis induction by tumors, embryonic tissues and lymphocytes. Cancer Res 36:3435–3440, 1976
Jampol LM, Goldbaum MH: Peripheral proliferative retinopathies. Surv Ophthalmol 25:1–14, 1980
Folkman J: Tumor angiogenesis. Adv Cancer Res 43:175–203, 1985
Taylor S, Folkman J: Protamine is an inhibitor of angiogenesis. Nature 297:307–312, 1982
Heuser SL, Taylor HS, Folkman J: Prevention of carcinomatosis and bloody malignant ascites in the rat by an inhibitor of angiogenesis. J Surg Res 36:244–250, 1984
Maragoudakis ME, Sarmonika M, Panoutsacopoulou M: Inhibition of basement membrane biosynthesis prevents angiogenesis. J Pharmacol Exp Ther 244:729–733, 1988
Maragoudakis ME, Kalinsky HJ, Wasvary J: Effect of LDOPA, GPA1734 and other agents on basement membrane biosynthesis. J Pharmacol Exp Ther 204:372–383, 1978
Watthey JWH, Doebel KJ, Vernay HF, Lopano AL: Studies on the synthesis of benzo[b]quinolizinium salts. J Org Chem 38:4170–4172, 1973
Maragoudakis ME, Panoutsacopoulou M, Sarmonika M: Rate of basement membrane biosynthesis as an index to angiogenesis. Tissue and Cell 20:531–539, 1988
Folkman J, Cotran RS: Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 16:207–248, 1976
Folkman J: Toward an understanding of angiogenesis. Search and discovery. Perspect Biol Med 29:10–35, 1985
Clark CC, Tomichek EA, Kozalka TR, Minor RR, Kefalides NA: The embryonic parietal yolk sac. The role of parietal endoderm in the biosynthesis of basement membrane collagen and glycoproteins in vitro. J Biol Chem 250:5259–5267, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Missirlis, E., Karakiulakis, G. & Maragoudakis, M.E. Antitumor effect of GPA1734 in rat Walker 256 carcinoma. Invest New Drugs 8, 145–147 (1990). https://doi.org/10.1007/BF00177249
Issue Date:
DOI: https://doi.org/10.1007/BF00177249